3rd Circ. To Hear Class Cert. Appeal In Lamictal Case
The Third Circuit on Monday agreed to hear an appeal from GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. as they look to nix a class certification for buyers accusing the drugmakers...To view the full article, register now.
Already a subscriber? Click here to view full article